Search results for: “Matthew Riddle”
-
Although incomplete, data indicate strong link between diabetes and COVID-19
The ADA Diabetes Care Symposium, with speakers Edward W. Gregg, PhD, and Linda DiMeglio, MD, MPH, focused on minimizing risks for people with diabetes during the pandemic. This population accounts for 30% to 40% of hospitalized COVID-19 patients.
-
Experts will discuss strategies to minimize COVID-19 risks for diabetes patients
The 2021 Diabetes Care Symposium, featuring speakers Matthew C. Riddle, MD, and Paresh Dandona, MD, PhD, will examine how to mitigate the threefold risk for severe COVID-19 infection among diabetes patients.
-
Experts offer their long-term perspectives during annual Diabetes Care Symposium
During the ninth annual Diabetes Care Symposium, a panel of world-renowned clinicians and researchers emphasized the need to consider all aspects of diabetes over long periods of time rather than relying on short-term clinical studies, single clinical assessments of individual patients, and short-term therapeutic goals. Diabetes Care Editor in Chief Matthew C. Riddle, MD, moderated…
-
REWIND trial: Dulaglutide reduces cardiovascular disease in type 2 diabetes patients
Dulaglutide, an injectable GLP-1 receptor agonist, can be considered for both primary and secondary cardiovascular prevention in middle-aged and older patients with type 2 diabetes and cardiovascular risk factors, according to results from the REWIND trial reported by Hertzel C. Gerstein, MD, MSc, FRCPC, and Matthew C. Riddle, MD.